Skip to main content
SpringerLink
Log in

Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

Diabetic pregnancy frequently results in macrosomia or fetal obesity. It seems that the anomalies in carbohydrate and lipid metabolism in macrosomic infants of diabetic mothers are due to maternal hyperglycemia, which leads to fetal hyperinsulinemia. We have developed a rat model of macrosomic offspring and assessed the onset of obesity in these animals. The macrosomic offspring born to diabetic mothers are prone to the development of glucose intolerance and obesity as a function of age. It seems that in utero programing during diabetic pregnancy creates a “metabolic memory” which is responsible for the development of obesity in macrosomic offspring. We have demonstrated that the metabolism of lipids, and altered anti-oxidant status and immune system are implicated in the etiopathology of obesity in these animals. We have reported beneficial effects of n-3 polyunsaturated fatty acids (PUFAs) in obese animals, born to diabetic dams.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Merzouk, H., Bouchenak, M., Loukidi, B., Prost, J., & Belleville, J. (2000). Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition. Journal of Clinical Pathology, 53, 917–923.

    Article  PubMed  CAS  Google Scholar 

  2. Meshari, A. A., De Silva, S., & Rahman, I. (1990). Fetal macrosomia-maternal risks and fetal outcome. International Journal of Gynaecology and Obstetrics, 32, 215–222.

    Article  PubMed  CAS  Google Scholar 

  3. Miller, J. M., Brown, H. L., Pastorek, J. G., & Gabert, H. A. (1988). Fetal overgrowth. Diabetic versus non diabetic. Journal of Ultrasound in Medicine, 7, 577–579.

    PubMed  Google Scholar 

  4. Sacks, D. A., Chen, W., Greespoon, J. S., & Wolde-Tsadik, G. (1997). Should the same glucose values be targeted for type 1 as for type 2 diabetics in pregnancy? American Journal of Obstetrics and Gynecology, 177, 1113–1119.

    Article  PubMed  CAS  Google Scholar 

  5. Adesina, O. A., & Olayemi, O. (2003). Fetal macrosomia at the university college hospital, Ibadan: a 3-year review. Journal of Obstetrics and Gynaecology, 23, 30–33.

    Article  PubMed  CAS  Google Scholar 

  6. Sacks, D. A. (1993). Fetal macrosomia, and gestational diabetes: What’s the problem? Obstetrics and Gynecology, 81, 775–781.

    PubMed  CAS  Google Scholar 

  7. Nassar, A. H., Usta, I. M., Khalil, A. M., Melhem, Z. I., Nakad, T. I., & Abu Musa, A. A. (2003). Fetal macrosomia (≥4500 g): Perinatal outcome of 231 cases according to the mode of delivery. Journal of Perinatology, 23, 136–141.

    Article  PubMed  Google Scholar 

  8. Conway, D. L. (2002). Delivery of the macrosomic infant: Cesarean section versus vaginal delivery. Seminars in Perinatology, 26, 225–231.

    Article  PubMed  Google Scholar 

  9. Taylor, R., Lee, C., Kyne-Grzebalski, D., Marshall, S. M., & Davison, J. M. (2002). Clinical outcomes of pregnancy in women with type 1 diabetes. Obstetrics and Gynecology, 99, 537–541.

    Article  PubMed  Google Scholar 

  10. Edelman, R. (1981). Obesity: Does it modulate infectious disease and immunity. Progress in Clinical and Biological Research, 67, 327–337.

    PubMed  CAS  Google Scholar 

  11. Herrera, E., & Amusquivar, E. (2000). Lipid metabolism in the fetus and the newborn. Diabetes/Metabolism Research and Reviews, 16, 202–210.

    Article  PubMed  CAS  Google Scholar 

  12. Pribylova, H., & Dvorakova, L. (1996). Long-term prognosis of infants of diabetic mothers. Relationship between metabolic disorders in newborns and adult offspring. Acta Diabetologica, 33, 30–34.

    Article  PubMed  CAS  Google Scholar 

  13. Merzouk, H., Madani, S., Prost, J., Loukidi, B., Meghilli-Bouchenak, M., & Belleville, J. (1999). Changes in serum lipid and lipoprotein concentrations and compositions at birth and after one month of life in macrosomic infants of insulin-dependent diabetic mothers. European Journal of Paediatrics, 158, 750–756.

    Article  CAS  Google Scholar 

  14. Merzouk, H., Madani, S., Chabane Sari, D., Prost, J., Bouchenak, M., & Belleville, J. (2000). The time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of streptozotocin-induced mild diabetic rats. Clinical Science, 98, 21–30.

    Article  PubMed  CAS  Google Scholar 

  15. Cordero, L., & Landon, M. (1993). Infant of the diabetic mother. Clinics in Perinatology, 20, 635–648.

    PubMed  CAS  Google Scholar 

  16. Plagemann, A., Harder, T., Kohlhoff, R., Rohde, W., & Dorner, G. (1997). Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes. Diabetologia, 40, 1094–1100.

    Article  PubMed  CAS  Google Scholar 

  17. Schwartz, R., & Teramo, K. A. (2000). Effects of diabetic pregnancy on the fetus, and newborn. Seminars in Perinatology, 24, 120–135.

    Article  PubMed  CAS  Google Scholar 

  18. Sameshima, H., Kamitomo, M., Kajiya, S., Kai, M., Furukawa, S., & Ikenoue, S. (2000). Early glycemic control reduces large-for-gestational-age infants in 250 Japanese gestational diabetes pregnancies. American Journal of Perinatology, 17, 371–376.

    Article  PubMed  CAS  Google Scholar 

  19. Jimenez-Moleon, J. J., Bueno-Cavanillas, A., Luna-del-Castillo, J., Garcia-Martin, M., Lardelli-Claret, P., & Galvez-Gargas, R. (2002). Impact of different levels of carbohydrate intolerance on neonatal outcomes classically associated with gestational diabetes mellitus. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 102, 36–41.

    Article  PubMed  Google Scholar 

  20. Fowden, A. L. (1989). The role of insulin in prenatal growth. Journal of Developmental Physiology, 12, 173–182.

    PubMed  CAS  Google Scholar 

  21. Barker, D. J. (1995). Fetal origins of coronary heart disease. British Medical Journal, 311, 171–174.

    PubMed  CAS  Google Scholar 

  22. Palinski, W., & Napoli, G. (2002). The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. The FASEB Journal, 16, 1348–1360.

    Article  PubMed  CAS  Google Scholar 

  23. Napoli, C., D’Armiento, F. P., Mancini, F. P., Witztum, J. L., Palumbo, G., & Palinski, W. (1997). Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of LDL and its oxidation precede monocyte recruitment into early atherosclerotic lesions. The Journal of Clinical Investigation, 100, 2680–2690.

    PubMed  CAS  Google Scholar 

  24. Vogel, R. A., Coretti, M. C., & Plotnick, G. D. (1997). Effect of a single high-fat meal on endothelial function in healthy subjects. The American Journal of Cardiology, 79, 350–354.

    Article  PubMed  CAS  Google Scholar 

  25. Merzouk, H., & Khan N. A. (2003). Implication of lipids in macrosomia of diabetic pregnancy: Can n-3 polyunsaturated fatty acids exert beneficial effects? Clinical Science (London), 105, 519–529.

    Google Scholar 

  26. Desai, M., Crowther, N., Ozanne, S. E., Lucas, A., & Hales, C. N. (1995). Adult glucose and lipid metabolism may be programmed during fetal life. Biochemical Society Transactions, 23, 331–335.

    PubMed  CAS  Google Scholar 

  27. Phillips, D. I. W. (1996). Insulin resistance as a programmed response to fetal undernutrition. Diabetologia, 39, 1119–1122.

    PubMed  CAS  Google Scholar 

  28. Dorner, G., & Plagemann, A. (1994). Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Hormone and Metabolic Research, 26, 213–221.

    PubMed  CAS  Google Scholar 

  29. Lautala, P., Puukka, R., Knip, M., & Perkkila, L. (1988). Postnatal decrease in insulin binding to erythrocytes in infants of diabetic mothers. The Journal of Clinical Endocrinology and Metabolism, 66, 696–701.

    Article  PubMed  CAS  Google Scholar 

  30. Foufelle, F., & Ferre, P. (2002). New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory-element-binding protein-1c. Biochemical Engineering Journal, 366, 377–391.

    Article  CAS  Google Scholar 

  31. Azzout-Marniche, D., Becard, D., Guichard, C., Foretz, P., & Foufelle, F. (2000). Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c). transcriptional activity in rat hepatocytes. Biochemical Engineering Journal, 350, 389–393.

    Article  CAS  Google Scholar 

  32. Edwards, P. A., Tabor, D., Kast, H. R., & Venkateswaran, A. (2000). Regulation of gene expression by SREBP and SCAP. Biochimica et Biophysica Acta, 1529, 103–113.

    PubMed  CAS  Google Scholar 

  33. Wilentz, R. E., Witters, L. A., & Pizer, E. S. (2000). Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are coexpressed with sterol regulatory element binding protein and Ki-67 fetal tissues. Pediatric and Developmental Pathology, 3, 525–531.

    Article  PubMed  CAS  Google Scholar 

  34. Yura, S., Itoh, H., Sagawa, N., Yamamoto, H., Masuzaki, H., Nakao, K., Kawamura, M., Takemura, M., Kakui, K., Ogawa, Y., & Fujii S. (2005). Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metabolism, 1, 371–378.

    Article  PubMed  CAS  Google Scholar 

  35. Merzouk, H., Madani, S., Korso, N., Bouchenak, M., Prost, J., & Belleville, J. (2000). Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control. The Journal of Laboratory and Clinical Medicine, 136, 441–448.

    Article  PubMed  CAS  Google Scholar 

  36. Cowett, R. M., & Schartz, R. (1982). The infant of diabetic mother. Pediatric Clinics of North America, 29, 1213–1231.

    PubMed  CAS  Google Scholar 

  37. Kalkhoff, R. K. (1991). Impact of maternal fuels and nutritional state on fetal growth. Diabetes, 40, 61–65.

    PubMed  Google Scholar 

  38. Raivio, K. O. (1985). Carbohydrate and lipid abnormalities in infants of diabetic mothers. Clinical Pediatrics, 197, 159–162.

    CAS  Google Scholar 

  39. Rovamo, L. M., Taskinen, M. R., Kuusi, J., & Raivio, K. O. (1986). Postheparin plasma lipoprotein and hepatic lipase activities in hyperinsulinemic infants of diabetic mothers and in large for date infants at birth. Pediatric Research, 20, 623–626.

    PubMed  CAS  Google Scholar 

  40. Knopp, R. H., Warth, M. R., Charles, D., Childs, M., Li, J. R., & Mabuchi, H. Van (1986). Lipoprotein metabolism in pregnancy, fat transport to the fetus, and the effects of diabetes. Biology of the Neonate, 50, 297–317.

    Google Scholar 

  41. Oh, W., Gelardi, N. L., & Cha, C. J. (1988). Maternal hyperglycemia in pregnant rats: Its effects on growth and carbohydrate metabolism in the offspring. Metabolism: Clinical and Experimental, 37, 1146–1151.

    CAS  Google Scholar 

  42. Gelardi, N. L., Cha, C. J., & Oh, W. (1990). Glucose metabolism in adipocytes of obese offspring of mild hyperglycemic rats. Pediatric Research, 28, 641–645.

    Article  PubMed  CAS  Google Scholar 

  43. Merzouk, H., Madani, S., Boualga, A., Prost, J., Bouchenak, M., & Belleville, J. (2001). Age-related changes in cholesterol metabolism in macrosomic offspring of rats with streptozotocin-induced diabetes. Journal of Lipid Research, 42, 1152–1159.

    PubMed  CAS  Google Scholar 

  44. Merzouk, H., Madani, S., Hichami, A., Prost, J., Belleville, J., & Khan, N. A. (2002). Age-related changes in fatty-acid composition of liver and serum very-low-density lipoprotein lipids in obese offspring of streptozotocin-induced diabetes rats. Obesity Research, 10, 703–714.

    PubMed  CAS  Google Scholar 

  45. Merzouk, H., Madani, S., Hichami, A., Prost, J., Moutairou, K., Belleville, J., & Khan, N. A. (2002). Impaired lipoprotein metabolism in obese offspring of streptozotocin-induced diabetic rats. Lipids, 37, 773–781.

    Article  PubMed  CAS  Google Scholar 

  46. Gelardi, N. L., Cha, C. J., & Oh, W. (1991). Evaluation of insulin sensitivity in obese offspring of diabetic rats by hyperinsulinemic-euglycemic clamp technique. Pediatric Research, 30, 40–44.

    PubMed  CAS  Google Scholar 

  47. Kissebah, A. H., Freedman, D. S., & Peiris, A. N. (1989). Health risks of obesity. The Medical Clinics of North America, 73, 111–138.

    PubMed  CAS  Google Scholar 

  48. Del Prato, S., Enzi, G., Vigili de Kreutzenberg, S., Lisato, G., Riccio, A., Maifreni, L., Iori, E., Zurlo, F., Sergi, G., & Tiengo, A. (1990). Insulin regulation of glucose and lipid metabolism in massive obesity. Diabetologia, 33, 228–236.

    Article  PubMed  Google Scholar 

  49. Verges, B. L. (1999). Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes & Metabolism, 25(Suppl 3), 32–40.

    Google Scholar 

  50. Suckling, K. E., & Jackson, B. (1993). Animal models of human lipid metabolism. Progress in Lipid Research, 32, 1–2.

    Article  PubMed  CAS  Google Scholar 

  51. Boulange, A., Planche, E., & Gasquet, P. (1981). Onset and development of hypertriglyceridemia in the Zucker rat (fa/fa). Metabolism: Clinical and Experimental, 30, 1045–1052.

    CAS  Google Scholar 

  52. Bioletto, S., Golay, A., Munger, R., Kalix, B., & James, R. W. (2000). Acute hyperinsulinemia and very-low-density and low-density lipoprotein subfractions in obese subjects. The American Journal of Clinical Nutrition, 71, 443–449.

    PubMed  CAS  Google Scholar 

  53. Cohn, J. S., Nestel, P. J., & Turley, S. D. (1987). Metabolism of high-density lipoprotein in the hyperlipidemic, diabetic SHR/N-corpulent rat. Metabolism, 36, 230–236.

    Article  PubMed  CAS  Google Scholar 

  54. Mela, D. J., Cohen, R. S., & Kris-Etherton, P. M. (1987). Lipoprotein metabolism in a rat model of diet-induced adiposity. The Journal of Nutrition, 117, 1655–1662.

    PubMed  CAS  Google Scholar 

  55. Simopoulos, A. P. (1999). Essential fatty acids in health and chronic disease. The American Journal of Clinical Nutrition, 70, 560S-569S.

    PubMed  CAS  Google Scholar 

  56. Storlien, L. H., Hulbert, A. J. & Else, P. L. (1998). Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity. Current Opinion in Clinical Nutrition and Metabolic Care, 1, 559–563.

    Article  PubMed  CAS  Google Scholar 

  57. Rabini, R. A., Tesei, M., Galeazzi, T., Dousset, N., Ferretti, G., & Mazzanti, L. (1999). Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: A possible correlation with fatty acid composition. Molecular and Cellular Biochemistry, 199, 63–67.

    Article  PubMed  CAS  Google Scholar 

  58. Jones, D. B., Carter, R. D., Haitas, B., & Mann, J. I. (1983). Low phospholipid arachidonic acid values in diabetic platelets. British Medical Journal, 286, 173–175.

    Article  PubMed  CAS  Google Scholar 

  59. Yessoufou, A., Moutairou, K., Girard, A., Fatoke, M., Prost, J., Ahissou, H., Djrolo, F., Avode, G., Amoussou-Guenou, D., Hichami, A., & Khan, N. A. (2005). Antioxidant status in alcohol-related diabetes mellitus in Beninese subjects. Cellular and Molecular Biology, 51, 849–858.

    Google Scholar 

  60. Kamath, U., Rao, G., Raghothama, C., Rai, L., & Rao P. (1998). Erythrocyte indicators of oxidative stress in gestational diabetes. Acta Paediatrica, 87, 676–679.

    Article  PubMed  CAS  Google Scholar 

  61. Merzouk, S., Hichami, A., Madani, S., Merzouk, H., Berrouiguet, A.Y., Prost, J., Moutairou, K., Chabane-Sari, N., & Khan, N. A. (2003). Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. General Physiology and Biophysics, 22, 15–27.

    PubMed  CAS  Google Scholar 

  62. Hunt, J. V., Smith, C. C. T., & Wolf, S. P. (1990). Autoxidative glycosylation and possible involvment of peroxides and free radicals in LDL modification by glucose. Diabetes, 39, 1420–1424.

    Article  PubMed  CAS  Google Scholar 

  63. McLennan, S. V., Heffernan, S., Wright, L., Rae, C., Fisher, E., Yue, D. K., & Turtle, J. R. (1991). Changes in hepatic glutathione metabolism in diabetes. Diabetes, 40, 344–348.

    Article  PubMed  CAS  Google Scholar 

  64. Young, I. S., Torney, J. J., & Trimble, E. R. (1992). The effects of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat. Free Radical Biology & Medicine, 8, 752–758.

    Google Scholar 

  65. Yessoufou, A., Soulaimann, N., Merzouk, S. A., Moutairou, K., Ahissou, H., Prost, J., Simonin, A. M., Merzouk, H., Hichami, A., & Khan, N. A. (2006). N-3 Fatty acids modulate antioxidant status in diabetic rats and their macrosomic offspring. International Journal of Obesity (Lond), 30, 739–750.

    Article  CAS  Google Scholar 

  66. Dincer, Y., Alademir, Z., Ilkova, H., & Akcay, T. (2002). Susceptibility of glutatione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: Effect of glycemic control. Clinical Biochemistry, 35, 297–301.

    Article  PubMed  CAS  Google Scholar 

  67. Giordano, C. (1990). Immunobiology of normal and diabetic pregnancy. Immunology Today, 11, 301–303.

    Article  PubMed  CAS  Google Scholar 

  68. Roll, U., Scheeser, J., Standl, E., & Ziegler A. G. (1994). Alterations of lymphocytes subsets in children of diabetic mothers. Diabetologia, 37, 1132–1141.

    PubMed  CAS  Google Scholar 

  69. Di Mario, U., Dotta, F., Garguilo, P., Sutherland, J., Adreani, D., Guy, K., Pachi, A., & Fallacca, F. (1987). Immunology in diabetic pregnacy: Activated T-cells in diabetic mothers and neonates. Diabetologia, 30, 66–71.

    PubMed  CAS  Google Scholar 

  70. Lapolla, A., Sanzari, M. C., Znacanaro, F., Masin, M., Guerriero, A., Piva, I., Toniato, R., Erle, G., Plebani, M., & Fedele, D. (1999). Study on lymphocyte subpopulation in diabetic mothers at delivery and in their newborns. Diabetes, Nutrition & Metabolism, 12, 394–399.

    CAS  Google Scholar 

  71. Giordano, C., De Maria, R., Mattina, A., Stassi, G., Todaro, M., Pugliese, A., Galluzzo, G., Botta, R. M., & Galluzzo, A. (1982). Analysis of T-lymphocytte subsets after phyhemagglutinin stimulation in normal and type 1 diabetic mothers and their infants. American Journal of Reproductive Immunology, 28, 65–70.

    Google Scholar 

  72. El Mohandes, A., Touraine, J. L., Shurky, A. S., & Salle, B. (1982). Lymphocyte populations and reponses to mitogens in infants of diabetic mothers. Journal of Clinical & Laboratory Immunology, 8, 25–29.

    CAS  Google Scholar 

  73. Khan, N. A., Yessoufou, A., Minji, K., & Hichami, A. (2006). N-3 fatty acids modulate TH1 and TH2 dichotomy in diabetic pregnancy and macrosomia. Journal of Autoimmunity, 26, 268–277.

    Article  PubMed  CAS  Google Scholar 

  74. Guermouche, B., Yessoufou, A., Soulimane, N., Merzouk, H., Moutairou, K., Hichami, A., & Khan, N. A. (2004). N-3 fatty acids modulate T-cell calcium signaling in obese macrosomic rats. Obesity Research, 12, 1744–1753.

    PubMed  CAS  Google Scholar 

  75. Issemann, I., & Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347, 645–650.

    Article  PubMed  CAS  Google Scholar 

  76. Wahli, W. (2002). Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. Swiss Medical Weekly, 132, 83–91.

    PubMed  CAS  Google Scholar 

  77. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., & Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 137, 354–366.

    Article  PubMed  CAS  Google Scholar 

  78. Lichtenstein, A. H., Kennedy, E., Barrier, P., Danford, D., Ernst, N. D., Grundy, S. M., Leveille, G. A., Van Horn, L., Williams, C. L., & Booth, S. L. (1998). Dietary fat consumption and health. Nutrition Reviews, 56, 3–19.

    Article  Google Scholar 

  79. Horrocks, L. A., & Yeo, Y. K. (1999). Health benefits of docosahexaenoic acid (DHA). Pharmacological Research, 40, 211–225.

    Article  PubMed  CAS  Google Scholar 

  80. Sundram, K. (1997). Modulation of human lipids and lipoproteins by dietary palm oil and palm olein: A review. Asia Pacific Journal of Clinical Nutrition, 6, 12–16.

    Google Scholar 

  81. Norum, K. R. (1992). Dietary fat and blood lipids. Nutrition Reviews 50, 30–37.

    Article  PubMed  CAS  Google Scholar 

  82. Lewis, R. A., Austen, K. F., & Soberman, R. J. (1990). Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. The New England Journal of Medicine, 323, 645–655.

    Article  PubMed  CAS  Google Scholar 

  83. Feskens, E. J., Bowles, C. H., & Kromhout, D. (1991). Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care, 14, 935–941.

    Article  PubMed  CAS  Google Scholar 

  84. Storlien, L. H., Kraegen, E. W., Chisholm, D. J., Ford, G. L., Bruce, D. G., & Pascoe, W. S. (1987). Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science (Washington, D.C.)., 237, 885–888.

    Google Scholar 

  85. Storlien, L. H., Jenkins, A. B., Chrisholm, D. J., Pascoe, W. S., Jhouri, S., & Kraegen, E. W. (1991). Influence of dietary fat composition on development of insulin resistance in rats. Diabetes, 40, 280–289.

    Article  PubMed  CAS  Google Scholar 

  86. Lardinois, C. K., & Starich, G. H. (1991). Polyunsaturated fats enhance peripheral glucose utilization in rats. Journal of the American College of Nutrition, 10, 340–345.

    PubMed  CAS  Google Scholar 

  87. Soulimane-Mokhtari, N. A., Guermouche, B., Yessoufou, A., Saker, M., Moutairou, K., Hichami, A., Merzouk, H., & Khan, N. A. (2005). Modulation of lipid metabolism by n-3 polyunsaturated fatty acids in gestational diabetic rats and their macrosomic offspring. Clinical Science (Lond)., 09, 287–95.

    Google Scholar 

  88. Harris, W. S., Connor, W. E., Illingworth, D. R., Rothrock, D. W., & Foster, D. M. (1990). Effects of fish oil on VLDL triglyceride kinetics in humans. Journal of Lipid Research, 31, 1549–1558.

    PubMed  CAS  Google Scholar 

  89. Harris, W. S., Lu, G., Rambjor, G. S., Walen, A. I., Ontko, J. A., Cheng, Q., & Windsor, S. L. (1997). Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. The American Journal of Clinical Nutrition, 66, 254–260.

    PubMed  CAS  Google Scholar 

  90. Demke, D. M., Peters, G. R., Linet, O. I., Metzler, C. M., & Klott, K. A. (1988). Effects of a fish oil concentrate in patients with hypercholesterolemia. Atherosclerosis, 70, 73–80.

    Article  PubMed  CAS  Google Scholar 

  91. Harris, W. S. (1989). Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. Journal of Lipid Research, 30, 785–807.

    PubMed  CAS  Google Scholar 

  92. Sanchez-Muniz, F. J., Bastida, S., Viejo, J. M., & Terpstra, A. H. (1999). Small supplements of n-3 fatty acids change serum low density lipoprotein composition by decreasing phospholipid and apolipoprotein B concentrations in young adult women. European Journal of Clinical Nutrition, 38, 20–27.

    Article  CAS  Google Scholar 

  93. Wander, R. C., & Shi-Hua, Du. (2000). Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. The American Journal of Clinical Nutrition, 72, 731–737.

    PubMed  CAS  Google Scholar 

  94. Allard, J. P., Kurian, R., Aghdassi, E., Muggli, R., & Royall, D. (1997). Lipid peroxidation during n-3 fatty acid and vitamin E supplementation in humans. Lipids, 32, 535–541.

    Article  PubMed  CAS  Google Scholar 

  95. Nordoy, A., Bonaa, K. H., Nilsen, H., Berge, R. K., & Hansen, J. B. (1998). Ingerbresten OC. Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. Journal of Internal Medicine, 243, 163–170.

    Article  PubMed  CAS  Google Scholar 

  96. Ando, K., Nagata, K., Beppu, M., Kikugawa, K., Kawabata, T., Hasegawa, K., & Suzuki, M. (1998). Effect of n-3 fatty acid supplementation on lipid peroxidation and protein aggregation in rat erythrocyte membranes. Lipids, 33, 505–512.

    Article  PubMed  CAS  Google Scholar 

  97. Hunkar, T, Aktan, F, Ceylan, A, & Karasu, C. (2002). Antioxidants in Diabetes-Induced Complications (ADIC). Study Group. Effects of cod liver oil on tissue antioxidant pathways in normal and streptozotocin-diabetic rats. Cell Biochemistry and Function, 20, 297–302.

    Article  PubMed  CAS  Google Scholar 

  98. Gunes, A., Ceylan, A., Sarioglu, Y., Stefek, M., Bauer, V., & Karasu C. (2005). The Antioxidants in Diabetes-induced Complications (ADIC). Study Group. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundamental & Clinical Pharmacology, 19, 73–79.

    Article  CAS  Google Scholar 

  99. Kesavulu, M. M., Kameswararao, B., Apparao, Ch, Kumar, E. G., & Harinarayan, C. V. (2002). Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes & Metabolism, 28, 20–26.

    CAS  Google Scholar 

  100. Bittiner, S. B., Tucker, W. F. G., Cartwright, I., & Bleehen S. S. (1988). A Double-Blind randomised, placebo-controlled trial of fish oil in psoriasis. Lancet, 1, 378–380.

    Article  PubMed  CAS  Google Scholar 

  101. Kremer, J. M., Jubiz, W, Michalek, A, Rynes, R. I., Bartholonew, L. E., Bigaouette, J, Timchalck, M., Beeler, D., & Lininger, L. (1987). Fish oil fatty acid supplementation in active rheumatoid Arthrisis. Annals of Internal Medicine, 106, 479–503.

    Google Scholar 

  102. Konttinen, Y. T., Bergroth, V., Kinnunen, E., Nordstorm, D., & Kouri, T. (1987). Activated T-lymphocytes in patients with multiple sclerosis in clinical remission. Journal of the Neurological Sciences, 81, 133–139.

    Article  PubMed  CAS  Google Scholar 

  103. Barker, J. N. (1991). The patophysiology of psoriasis. Lancet, 338, 227–230.

    Article  PubMed  CAS  Google Scholar 

  104. Merrill, J. E., Mohlstorm, C., Uittenbogaart, C., Kermani-Arab V, Elisson, G. W., & Myers, L. W. (1984). Reponse and production of interleukin-2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis. Journal of Immunology, 133, 1931–1937.

    CAS  Google Scholar 

  105. Wolf, R. E., & Brelsford W.G. (1988). Soluble Interleukin-2 receptors in systemic lupus erythematosus. Arthritis and Rheumatism, 31, 729–735.

    Article  PubMed  CAS  Google Scholar 

  106. Calder, P. C., Bevan, S. J., Hunt, S. V., & Newshlome E. A. (1991). Effect of fatty acids on the proliferation of concavaline A-stimulated rat lymphnode lymphocytes. The International Journal of Biochemistry, 23, 579–588.

    Article  PubMed  CAS  Google Scholar 

  107. Tsang, W. M., Weyman, C., & Smith, A. D. (1977). Effect of fatty acids mixtures phyto haemmaglutinin-stimulated lymphocytes from different species. Biochemical Society Transactions, 15, 153–154.

    Google Scholar 

  108. Calder, P. C., Bevan S. J., & Newsholme E. A. (1992). The inhibition of T- lymphocyte proliferation by fatty acids is an eicosanoid-indepedant mechanism. Immunology, 75, 108–115.

    PubMed  CAS  Google Scholar 

  109. Buttke, T. M. (1984). Inhibition of lymphocyte proliferation by free fatty acids—I. Immunology, 53, 507–514.

    PubMed  CAS  Google Scholar 

  110. Soyland, E., Nenseter, M. S., Braathhen L., & Drevon, C. A. (1993). Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation in human T lymphoctes in vitro. European Journal of Clinical Investigation, 23, 112–121.

    Article  PubMed  CAS  Google Scholar 

  111. Wallace, A., Miles, E. A., Evans, C., Stock T. E., Yaqoob P., & Calder P. C. (2001). Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. Journal of Leukocyte Biology, 69, 449–457.

    PubMed  CAS  Google Scholar 

  112. Triboulot, C., Hichami, A., Denys, A., & Khan N. A. (2001). Dietary (n-3). polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats. The Journal of Nutrition, 131, 2364–2369.

    PubMed  CAS  Google Scholar 

  113. Khan, N. A., & Hichami, A. (2002). Role of n-3 polyunsaturated fatty acids in T-cell signalling. In G. Pandalai (Ed.), Recent advances in research in lipids (Vol. 6). Transworld Publications, Trivendrum, Kerala, India, pp. 65–78.

  114. Bonin, A., & Khan N. A. (2000). Regulation of calcium signalling by docosahexaenoic acid in human T-cells. Implication of CRAC channels. Journal of Lipid Research, 41, 277–284.

    PubMed  CAS  Google Scholar 

  115. Aires, V., Hichami, A., Moutairou, K., & Khan, N. A. (2003). Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells. British Journal of Pharmacology, 140, 1217–1226.

    Article  PubMed  CAS  Google Scholar 

  116. Denys, A., Hichami, A., & Khan N. A. (2001). Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. Journal of Lipid Research, 42, 2015–2020.

    PubMed  CAS  Google Scholar 

  117. Denys, A., Hichami, A., & Khan N. A. (2002). Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Molecular and Cellular Biochemistry, 232, 143–148.

    Article  PubMed  CAS  Google Scholar 

  118. Madani, S., Hichami, A., Legrand, A., Belleville, J., & Khan, N. A. (2001). Implication of acyl chain ofdiacylglycerols in activation of different isoforms of protein kinase C. The FASEB Journal, 15, 2595–2601.

    Article  PubMed  CAS  Google Scholar 

  119. Hichami, A., Morin, C., Rousseau, E., & Khan, N. A. (2005). Diacylglycerol-containing docosahexaenoic acid in acyl chain modulates airway smooth muscle tone. American Journal of Respiratory Cell and Molecular Biology, 33, 378–386.

    Article  PubMed  CAS  Google Scholar 

  120. Madani, S., Hichami, A., Charkaoui-Malki, M., & Khan, N. A. (2004). Diacylglycerols containing Omega 3 and Omega 6 fatty acids bind to RasGRP and modulate MAP kinase activation. The Journal of Biological Chemistry, 279, 1176–1183.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, UPRES Lipides & Signalisation Cellulaire, Université de Bourgogne, Dijon, France

    Naim Akhtar Khan

Authors
  1. Naim Akhtar Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naim Akhtar Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khan, N.A. Role of lipids and fatty acids in macrosomic offspring of diabetic pregnancy. Cell Biochem Biophys 48, 79–88 (2007). https://doi.org/10.1007/s12013-007-0019-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-007-0019-4

Keywords

Search

Navigation